FoggyIsle.XYZ | Market's view on Trellus Health.

There are concerns about the company’s future prospects and long-term viability after inheriting shares from a dividend payment.
The company’s app has a total of 180 downloads, no ratings, and is not ranked, which may indicate limited market penetration.
Some watchers are concerned about potential negative impacts on share price due to actions by major shareholders.
The company has an estimated market capitalization of £3.2 million and was burning through £0.55 million per month as of the end of 2023.
Observations were made regarding a significant shareholder increasing their stake, which could signal a potential attempt to take the company private.
A surprising stock sell-off occurred following what was perceived as a positive news release, leading to confusion among watchers.
The company announced a long-awaited deal in the U.S., but specifics were lacking, leading to doubts about its significance.
Concerns were raised about a potential “pump and dump” operation and an increase in short positions.
The company’s cash reserves are reportedly higher than its market capitalization, which sparked some intrigue.
The shift from a Direct-to-Consumer (D2C) model to a Business-to-Business (B2B) model was noted, with no current users and trials not expected to yield results until the second quarter of 2024.
Download figures for the company’s app were disappointingly low, with only 130 total downloads, raising concerns about the company’s ability to execute its business plan.
The recent investor call did not meet expectations, with the company trading close to its cash value and ongoing concerns about the slow pace of U.S. healthcare roll-outs for small companies.